Show simple item record
dc.description.abstractThe guideline covers the care of people who have signs and symptoms that develop during or after an infection consistent with COVID-19, that continue for more than 4 weeks and are not explained by an alternative diagnosis. It provides recommendations based on the current evidence and expert consensus, and will be adapted as new evidence emerges. Most people’s symptoms of COVID-19 resolve within 12 weeks. However, for a sizeable minority of people symptoms can persist or new ones develop, and can sometimes worsen, and have a continuing negative impact on their quality of life. Longer term impacts can include shortness of breath, fatigue, and problems involving the heart, lungs, kidneys, nervous system and muscles and joints.en_US
dc.subjectInfectious Diseasesen_US
dc.subjectCoronavirus Infectionsen_US
dc.subjectAcute Diseaseen_US
dc.subjectRisk Factorsen_US
dc.titleNICE, RCGP and SIGN publish guideline on managing the long-term effects of COVID-19en_US
eihealth.categoryClinical characterization and managementen_US
eihealth.categoryHealth systems and servicesen_US
eihealth.typeOther public health institution guidanceen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.contributor.corporatenameNational Institute for Health and Care Excellenceen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record